The Defeat Pediatric Brain Tumors program employees a team of renowned researchers, doctors, and neurosurgeons which make up our Strategic Scientific Advisory Council and is managed by a steering committee, currently consisting of NBTS board members. This committee will be open for membership to volunteers and leaders in the brain tumor community.
Dr. Roger Packer, MDM
Senior Vice-President, Center for Neuroscience and Behavioral Medicine, Gilbert Distinguished Professor of Neurofibromatosis, and is Director of both the Gilbert Neurofibromatosis Institute and the Brain Tumor Institute of Children’s National Health System; Professor of Neurology and Pediatrics at George Washington University and Clinical Professor of Neurosurgery at the University of Virginia in Charlottesville.
Strategic Scientific Advisory Council
Susan Blaney, MD
Deputy Director of the Texas Children’s Cancer and Hematology Centers; Executive Vice Chair, Department of Pediatrics, Baylor College of Medicine (BCM); Vice President, Clinical and Translational Research, BCM.
Richard Gilbertson, MD, PhD
Li Ka Shing Chair of Oncology and Director of the Cambridge Cancer Centre, England. (A Cancer Research UK Major Centre and OECI Comprehensive Cancer Centre)
Scott Pomeroy, MD, PhD
Neurologist-in-Chief and Chairman, Department of Neurology, Boston Children’s Hospital; Consultant, Pediatric Neuro-Oncology, Dana-Farber Cancer Institute; Bronson Crothers Prof. of Neurology, Harvard Medical School.
Raphael Rousseau, MD, PhD
Group Medical Director / Global Franchise Head, Pediatrics
Genentech, a member of the Roche Group
Professor, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA and Adjunct Professor, University of California, San Diego, La Jolla, CA
The Steering Committee has two co-chairs, and is organized into a series of solicitation committees, on which members of the Steering Committee will elect to serve.
These committees are:
- Leadership Gifts
- Major Gifts
- Community Gifts
Steering Committee Co-Chairs
Michael Nathanson, JD, LLM
Michael Nathanson is the Chair of the National Brain Tumor Society Board of Directors. He is also the Chief Executive Officer, President, and Chairman of The Colony Group, a leading independent wealth management company. He has been on the National Brain Tumor Society’s Board of Directors since 2011. He has been named eight times by Barron’s as one of the top 100 independent financial advisors in the nation. Mr. Nathanson has been living with a brain tumor since 2000.
Cord Schlobohm, DMD
Cord Schlobohm, DMD is the Vice Chair of the National Brain Tumor Society Board of Directors. He has been a practicing dentist in Bethesda, MD for over 25 years. Dr. Schlobohm became involved with the National Brain Tumor Society after losing his daughter to a brain tumor. He recently served as a patient advocate on the peer-reviewed Cancer Research Program of the Department of Defense, and has spoken on NPR on behalf of the National Brain Tumor Society.
For more information about joining the steering committee, contact Wendi Nance or 617 658 7035